CN1568324A - 用于治疗癌症的1－乙醛酰胺吲哚嗪 - Google Patents

用于治疗癌症的1－乙醛酰胺吲哚嗪 Download PDF

Info

Publication number
CN1568324A
CN1568324A CNA028202848A CN02820284A CN1568324A CN 1568324 A CN1568324 A CN 1568324A CN A028202848 A CNA028202848 A CN A028202848A CN 02820284 A CN02820284 A CN 02820284A CN 1568324 A CN1568324 A CN 1568324A
Authority
CN
China
Prior art keywords
substituted
alkyl
unsubstituted
ring
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA028202848A
Other languages
English (en)
Chinese (zh)
Inventor
古屋圭三
孙利军
小野光则
英伟文
李�浩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SBR Pharmaceuticals Inc
Original Assignee
SBR Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SBR Pharmaceuticals Inc filed Critical SBR Pharmaceuticals Inc
Publication of CN1568324A publication Critical patent/CN1568324A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CNA028202848A 2001-09-13 2002-09-13 用于治疗癌症的1－乙醛酰胺吲哚嗪 Pending CN1568324A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32202001P 2001-09-13 2001-09-13
US60/322,020 2001-09-13

Publications (1)

Publication Number Publication Date
CN1568324A true CN1568324A (zh) 2005-01-19

Family

ID=23253054

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA028202848A Pending CN1568324A (zh) 2001-09-13 2002-09-13 用于治疗癌症的1－乙醛酰胺吲哚嗪

Country Status (19)

Country Link
US (2) US6861436B2 (cg-RX-API-DMAC7.html)
EP (1) EP1432709B8 (cg-RX-API-DMAC7.html)
JP (1) JP2005504795A (cg-RX-API-DMAC7.html)
KR (1) KR20040053125A (cg-RX-API-DMAC7.html)
CN (1) CN1568324A (cg-RX-API-DMAC7.html)
AT (1) ATE300542T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002333626B2 (cg-RX-API-DMAC7.html)
BR (1) BR0212794A (cg-RX-API-DMAC7.html)
CA (1) CA2459886A1 (cg-RX-API-DMAC7.html)
DE (1) DE60205265T2 (cg-RX-API-DMAC7.html)
ES (1) ES2245747T3 (cg-RX-API-DMAC7.html)
IL (1) IL160810A0 (cg-RX-API-DMAC7.html)
IS (1) IS7176A (cg-RX-API-DMAC7.html)
MX (1) MXPA04002323A (cg-RX-API-DMAC7.html)
NO (1) NO20041035L (cg-RX-API-DMAC7.html)
NZ (1) NZ531700A (cg-RX-API-DMAC7.html)
PT (1) PT1432709E (cg-RX-API-DMAC7.html)
WO (1) WO2003022846A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200401996B (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI469982B (zh) * 2009-07-29 2015-01-21 Sanofi Aventis 環狀（氮雜）吲甲醯胺、其製備及其作為藥劑之用途
CN113603694A (zh) * 2021-07-16 2021-11-05 浙江工业大学 一种1,2-二酮类化合物及其制备方法和应用

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005504795A (ja) * 2001-09-13 2005-02-17 シンタ ファーマスーティカルズ コーポレイション 癌処置のための１−グリオキシリルアミドインドリジン類
US20040116462A1 (en) * 2002-12-12 2004-06-17 Mitsunori Ono Indolizine compounds
CA2496764A1 (en) * 2002-09-13 2004-03-25 Synta Pharmaceuticals Corp. Synthesis of indolizines
DE10318611A1 (de) 2003-04-24 2004-11-11 Elbion Ag 4-, 6- oder 7-Hydroxyindole mit N-Oxidgruppen und deren Verwendung als Therapeutika
WO2005099824A1 (en) * 2004-03-30 2005-10-27 Synta Pharmaceuticals, Corp. 1-glyoxylamide indolizines for treating lung and ovarian cancer
GB0413605D0 (en) 2004-06-17 2004-07-21 Addex Pharmaceuticals Sa Novel compounds
WO2006073938A2 (en) * 2004-12-30 2006-07-13 East Carolina University Method for the synthesis of 3-substituted indolizine and benzoindolizine compounds
CA2608890C (en) * 2005-05-20 2011-08-02 Alantos-Pharmaceuticals, Inc. Heterobicyclic metalloprotease inhibitors
US20070155738A1 (en) 2005-05-20 2007-07-05 Alantos Pharmaceuticals, Inc. Heterobicyclic metalloprotease inhibitors
US8404736B2 (en) * 2008-08-14 2013-03-26 Beta Pharma Canada Inc. Heterocyclic amide derivatives as EP4 receptor antagonists
CN102413825A (zh) 2009-04-29 2012-04-11 阿马里纳股份公司 含有epa和心血管剂的药物组合物以及使用其的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2287706A (en) 1994-03-21 1995-09-27 Fujisawa Pharmaceutical Co Indolizine derivatives
FR2757166B1 (fr) * 1996-12-12 1999-01-29 Rhone Poulenc Rorer Sa Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent
WO1998047507A1 (en) 1997-04-24 1998-10-29 Shionogi & Co., Ltd. Method for the treatment of stroke using n-heterocyclic glyoxylamide compounds
KR20010034881A (ko) 1998-05-21 2001-04-25 시오노 요시히코 ｓＰＬＡ2 억제 효과를 갖는 피롤로[1,2-ｂ]피리다진 유도체
CA2346334A1 (en) 1998-10-14 2000-04-20 Shionogi & Co., Ltd. Composition for treating or preventing ischemia reperfusion injury
US6461538B2 (en) * 1999-12-16 2002-10-08 Fuji Photo Film Co., Ltd. Production process for indolizine compounds and their use in organic light-emitting devices
JP2005504795A (ja) * 2001-09-13 2005-02-17 シンタ ファーマスーティカルズ コーポレイション 癌処置のための１−グリオキシリルアミドインドリジン類
US20040116462A1 (en) * 2002-12-12 2004-06-17 Mitsunori Ono Indolizine compounds

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI469982B (zh) * 2009-07-29 2015-01-21 Sanofi Aventis 環狀（氮雜）吲甲醯胺、其製備及其作為藥劑之用途
CN113603694A (zh) * 2021-07-16 2021-11-05 浙江工业大学 一种1,2-二酮类化合物及其制备方法和应用
CN113603694B (zh) * 2021-07-16 2022-07-22 浙江工业大学 一种1,2-二酮类化合物及其制备方法和应用

Also Published As

Publication number Publication date
JP2005504795A (ja) 2005-02-17
PT1432709E (pt) 2005-10-31
NZ531700A (en) 2006-10-27
IS7176A (is) 2004-03-11
ES2245747T3 (es) 2006-01-16
BR0212794A (pt) 2004-10-05
DE60205265D1 (de) 2005-09-01
EP1432709A1 (en) 2004-06-30
NO20041035L (no) 2004-04-30
ZA200401996B (en) 2005-05-31
AU2002333626B2 (en) 2006-06-29
IL160810A0 (en) 2004-08-31
US6861436B2 (en) 2005-03-01
MXPA04002323A (es) 2005-04-08
CA2459886A1 (en) 2003-03-20
EP1432709B1 (en) 2005-07-27
DE60205265T2 (de) 2006-03-30
KR20040053125A (ko) 2004-06-23
ATE300542T1 (de) 2005-08-15
HK1063322A1 (en) 2004-12-24
EP1432709B8 (en) 2005-11-02
WO2003022846A1 (en) 2003-03-20
US20030153759A1 (en) 2003-08-14
US20040214850A1 (en) 2004-10-28

Similar Documents

Publication Publication Date Title
CN1308327C (zh) 咪唑并吡啶衍生物
CN1191236C (zh) 取代的6,6－杂－双环衍生物
CN1239485C (zh) 作为IL－1β和TNF－α抑制剂的二苯酮类
CN1152031C (zh) 具有血管生成抑制活性的异喹啉衍生物
CN1273451C (zh) 哌啶mch拮抗剂及其治疗肥胖症的用途
CN1127493C (zh) 苯环的2－位被取代的1－(n－苯氨基烷基)－哌嗪衍生物
CN1246319C (zh) 氨基(硫)醚衍生物
CN1543346A (zh) 新化合物
CN1426398A (zh) 稠合杂芳基衍生物
CN1688548A (zh) 喹啉抗生素中间体的制备方法
CN1136039A (zh) [3-(4-苯基哌嗪-1-基)丙氨基、硫基和氧基]-吡啶、嘧啶和苯衍生物
CN1568324A (zh) 用于治疗癌症的1－乙醛酰胺吲哚嗪
CN1795195A (zh) 新颖的吡啶并吡嗪及其作为激酶调节剂的用途
CN1511151A (zh) 3-喹啉-2(1h)-亚基二氢吲哚-2-酮衍生物
CN1230432C (zh) 取代的苯基－哌嗪衍生物及其制备和用途
CN101035761A (zh) 作为聚(adp-核糖)聚合酶(parp)抑制剂、治疗由坏死或细胞程序死亡导致的组织损伤或疾病的3，6－取代的5－芳基氨基－1h－吡啶－2－酮衍生物和相关化合物
CN1794990A (zh) 代谢型谷氨酸受体－5的二芳基取代吡咯调节剂
WO2011002103A2 (en) A cycloalkane derivative
CN1244577C (zh) 4－苯基－1－哌嗪基、－哌啶基和－四氢吡啶基衍生物
CN1196721A (zh) 杂芳基取代的丙烯酰胍衍生物及其医药组合物
CN1323306A (zh) 萘啶衍生物
CN1735618A (zh) 用作ltd4拮抗剂的新型三环衍生物
CN1807413A (zh) 咔唑磺酰胺衍生物及其制备方法
CN1280289C (zh) 用作ip拮抗剂的烷氧基羰基氨基杂芳基羧酸衍生物
CN88101782A (zh) 抗心律不齐药

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication